Marknadsnyheter

PolarCool finalist for Sports Technology Awards

Published

11 månader ago

13 februari, 2024

Tanalys

The med-tec company PolarCool’s concussion treatment product, PolarCap®, has been recognized by being shortlisted in the medical category of the Sports Technology Awards, the premier platform highlighting and celebrating technological advancements in sports. PolarCap® is shortlisted in the category of Sports and Exercise Medical.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussions. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.

The Sports Technology Awards (https://www.sportstechgroup.org/sports-technology-awards), renowned as the pinnacle of global recognition for tech-driven progress in sports, has singled out PolarCool for consideration in the Sports and Exercise Medical Category. This category honors advancements in medical and scientific technology geared towards monitoring, diagnosing, treating, and rehabilitating athletes across all levels. Areas of focus include biomechanics, injury assessment and prevention, medical diagnostic imaging, prosthetics and assistive devices, rehabilitation, sports nutrition, and physiology, as well as telemedicine and remote monitoring.

With entries spanning across 5 continents, representing over 30 countries, and encompassing more than 50 sports, the Sports Technology Awards receive significant attention from the global sports community. The annual cycle commences with entries opening in September, followed by a shortlisting process conducted by over 50 industry experts who review all submissions. The 2024 Awards ceremony is set to take place in London, where the most outstanding innovations in sports technology are celebrated and honored.

This global recognition and exposure of PolarCap® being shortlisted among world-leading sports technology brands is very impactful and highlights the treatment on the global stage. This recognition confirms PolarCool’s role as a pioneer and a game-changer in athletes’ concussion recovery.

PolarCool’s CEO Erik Andersson comments:

-I am very proud of PolarCool being shortlisted by the Sport Technology Awards. The dedication and hard work behind the innovation resulting in PolarCap® is impressive. This nomination reaffirms our commitment to advancing the treatment of concussions with PolarCap® to the benefit of athletes worldwide. We are honored to be considered among the leaders in the Sports and Exercise Medical Category.

For more information

Erik Andersson – CEO PolarCool AB (publ.)
+46 – 738 60 57 00
E-mail: erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.

Marknadsnyheter

Exelity AB (publ) offentliggör NAV-kurs 104,64 för december 2024

Published

2 timmar ago

2 januari, 2025

Tanalys

Stockholm 2 januari 2025 – Exelity AB (publ), (nedan kallat Fonden), i vilken allmänheten och institutionella investerare givits möjlighet att teckna Vinstandelslån.

Exelity AB (publ) är noterat på Nordic AIF Sweden-segmentet under Main Regulated vid NGM i Stockholm.
Fondens namn på NGM är Exelity Kapitalandelsbevis 1 med symbolen EXLY1.

– Fondens NAV-kurs är satt till 104,64 för december 2024

(NAV kursen anges i procent av nominellt belopp)

Fondens utveckling

Denna information är sådan som Exelity AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning (EU) 596/2014. Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 2 januari 2025 kl.15:25 CET

För ytterligare information, vänligen kontakta:
Marlon Värnik, VD, tfn +46-70-270 71 63, marlon@exelity.se

Om Finserve AB
Finserve Nordic AB står under tillsyn och kontroll av Finansinspektionen i Sverige, med tillstånd att bedriva verksamhet inkluderande förvaltning av UCITS, AIF, diskretionär portföljförvaltning (LAIF/LVF),och investeringsrådgivning.

Marknadsnyheter

Market Notice 1/25 – Hunter Capital AB (publ)´s share, HUNTER, is transferred to the ordinary list on January 2, 2025

Published

2 timmar ago

2 januari, 2025

Tanalys

Following today’s press release from Spotlight, the company’s share has been moved to Spotlight’s ordinary list.

The share has been listed on Spotlight’s Observation List since December 2, 2024

Information about the share:
Shortname: HUNTER
ISIN-code: SE0022087649
Orderbook-ID: 303573
CFI: ESVUFR
FISN: HUNTERCAP/SH
Organization number: 559223-8827
LEI: 549300OXLYWDJAFSB231

Stockholm January 2, 2025

Spotlight Stock Market
08-511 68 000
backoffice@spotlightstockmarket.com

Marknadsnyheter

Hunter Capital AB:s aktie, HUNTER, återförs till ordinarie lista

Published

2 timmar ago

2 januari, 2025

Tanalys

Pressmeddelande 2025-01-02

(for English version see below)

Hunter AB:s aktie har sedan 2 december 2024 handlats på Spotlight Stock Markets observationslista.

Med hänvisning till dagens pressmeddelande från Oliver Aleksov och Milad Pournouri har Spotlight Stock Market beslutat att bolagets aktie ska återföras till Spotlight Stock Markets ordinarie lista från och med idag, den 2 januari 2025.

Spotlight Stock Market
08-511 68 000
E-post: trading@spotlightstockmarket.com

Om Spotlight

Spotlight Stock Market är handelsplats som vill göra det enklare och tryggare och synligare för tillväxtbolag att bli och vara noterade. Samtidigt erbjuder företaget investerare möjligheten att bli delägare i tillväxtbolag på ett enklare och tryggare sätt. Hos Spotlight Stock Market finns fler än 140 noterade tillväxtbolag från olika branscher. Spotlight Stock Market grundades 1997, har 20 anställda och huvudkontor i Stockholm. Läs mer på www.spotlightstockmarket.com

Press release January 2, 2025

Hunter capital AB´s share, HUNTER, will be transferred to Spotlight Stock Market’s ordinary list

Since December 2, 2024 Hunter Capital AB:s share has been traded on Spotlight Stock Market’s observation list.

With reference to today’s press release from Oliver Aleksov and Milad Pournouri, Spotlight Stock Market has decided to transfer the company’s share to Spotlight Stock Market’s ordinary list as of today January 2, 2025.

Spotlight Stock Market
+ 46 8-511 68 000
E-mail: trading@spotlightstockmarket.com

About Spotlight

Spotlight Stock Market is a market place that wants to make it easier, safer and more visible for growth companies to become and be listed. The company also offers investors the opportunity to become shareholders in growth companies in an easier and safer way. At Spotlight Stock Market there are more than 140 listed growth companies from different industries. Spotlight Stock Market was founded 1997, have 20 employees and head office in Stockholm. Read more at www.spotlightstockmarket.com